BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15294877)

  • 1. Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells.
    Karniski LP
    Hum Mol Genet; 2004 Oct; 13(19):2165-71. PubMed ID: 15294877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.
    Karniski LP
    Hum Mol Genet; 2001 Jul; 10(14):1485-90. PubMed ID: 11448940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations.
    Superti-Furga A; Rossi A; Steinmann B; Gitzelmann R
    Am J Med Genet; 1996 May; 63(1):144-7. PubMed ID: 8723100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.
    Rossi A; van der Harten HJ; Beemer FA; Kleijer WJ; Gitzelmann R; Steinmann B; Superti-Furga A
    Hum Genet; 1996 Dec; 98(6):657-61. PubMed ID: 8931695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.
    Hästbacka J; Superti-Furga A; Wilcox WR; Rimoin DL; Cohn DH; Lander ES
    Am J Hum Genet; 1996 Feb; 58(2):255-62. PubMed ID: 8571951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia.
    Maeda K; Miyamoto Y; Sawai H; Karniski LP; Nakashima E; Nishimura G; Ikegawa S
    Am J Med Genet A; 2006 Jun; 140(11):1143-7. PubMed ID: 16642506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia.
    Miyake A; Nishimura G; Futami T; Ohashi H; Chiba K; Toyama Y; Furuichi T; Ikegawa S
    J Hum Genet; 2008; 53(8):764-768. PubMed ID: 18553123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family.
    Dwyer E; Hyland J; Modaff P; Pauli RM
    Am J Med Genet A; 2010 Dec; 152A(12):3043-50. PubMed ID: 21077202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.
    Rossi A; Superti-Furga A
    Hum Mutat; 2001 Mar; 17(3):159-71. PubMed ID: 11241838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans.
    Satoh H; Susaki M; Shukunami C; Iyama K; Negoro T; Hiraki Y
    J Biol Chem; 1998 May; 273(20):12307-15. PubMed ID: 9575183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.
    Rossi A; Kaitila I; Wilcox WR; Rimoin DL; Steinmann B; Cetta G; Superti-Furga A
    Matrix Biol; 1998 Oct; 17(5):361-9. PubMed ID: 9822202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.
    Rossi A; Bonaventure J; Delezoide AL; Superti-Furga A; Cetta G
    Eur J Biochem; 1997 Sep; 248(3):741-7. PubMed ID: 9342225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the DTDST gene in a fetus with achondrogenesis type 1B.
    Cai G; Nakayama M; Hiraki Y; Ozono K
    Am J Med Genet; 1998 Jun; 78(1):58-60. PubMed ID: 9637425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 17 beta-estradiol on diastrophic dysplasia sulfate transporter activity in otosclerotic bone cell cultures and SaOS-2 cells.
    Imauchi Y; Lainé P; Sterkers O; Ferrary E; Bozorg Grayeli A
    Acta Otolaryngol; 2004 Oct; 124(8):890-5. PubMed ID: 15513522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.
    Forlino A; Piazza R; Tiveron C; Della Torre S; Tatangelo L; Bonafè L; Gualeni B; Romano A; Pecora F; Superti-Furga A; Cetta G; Rossi A
    Hum Mol Genet; 2005 Mar; 14(6):859-71. PubMed ID: 15703192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal recessive multiple epiphyseal dysplasia with homozygosity for C653S in the DTDST gene: double-layer patella as a reliable sign.
    Mäkitie O; Savarirayan R; Bonafé L; Robertson S; Susic M; Superti-Furga A; Cole WG
    Am J Med Genet A; 2003 Oct; 122A(3):187-92. PubMed ID: 12966518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Finnish founder mutation for diastrophic dysplasia (DTD).
    Hästbacka J; Kerrebrock A; Mokkala K; Clines G; Lovett M; Kaitila I; de la Chapelle A; Lander ES
    Eur J Hum Genet; 1999 Sep; 7(6):664-70. PubMed ID: 10482955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.
    Rossi A; Cetta G; Piazza R; Bonaventure J; Steinmann B; Supereti-Furga A
    Pediatr Pathol Mol Med; 2003; 22(4):311-21. PubMed ID: 14692227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and characterization of the 5'-flanking region of the mouse diastrophic dysplasia sulfate transporter gene.
    Kobayashi T; Sugimoto T; Saijoh K; Fujii M; Chihara K
    Biochem Biophys Res Commun; 1997 Sep; 238(3):738-43. PubMed ID: 9325159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types.
    Haila S; Hästbacka J; Böhling T; Karjalainen-Lindsberg ML; Kere J; Saarialho-Kere U
    J Histochem Cytochem; 2001 Aug; 49(8):973-82. PubMed ID: 11457925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.